Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

A Randomized, Controlled Multisite Study of Behavioral Interventions for Veterans with Mental Illness and Antipsychotic Medication-Associated Obesity.

Erickson ZD, Kwan CL, Gelberg HA, Arnold IY, Chamberlin V, Rosen JA, Shah C, Nguyen CT, Hellemann G, Aragaki DR, Kunkel CF, Lewis MM, Sachinvala N, Sonza PA, Pierre JM, Ames D.

J Gen Intern Med. 2017 Apr;32(Suppl 1):32-39. doi: 10.1007/s11606-016-3960-3.

PMID:
28271424
2.

Development of diabetes mellitus associated with quetiapine: A case series.

Nanasawa H, Sako A, Mitsutsuka T, Nonogaki K, Kondo T, Mishima S, Uju Y, Ito T, Enomoto T, Hayakawa T, Yanai H.

Medicine (Baltimore). 2017 Jan;96(3):e5900. doi: 10.1097/MD.0000000000005900.

3.

Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.

Kaino K, Kumagai R, Furukawa S, Isono M, Muramatsu A, Fujii M, Muta Y, Asada T, Fujihara K, Yagyu H.

J Diabetes Investig. 2017 May;8(3):392-394. doi: 10.1111/jdi.12597. Epub 2017 Jan 6.

4.

Olanzapine induced biochemical and histopathological changes after its chronic administration in rats.

Shah R, Subhan F, Ali G, Ullah I, Ullah S, Shahid M, Ahmad N, Fawad K.

Saudi Pharm J. 2016 Nov;24(6):698-704. Epub 2015 Jun 18.

5.

Effect of Psychotropic Drugs on Development of Diabetes Mellitus in Patients With Alzheimer's Disease.

Chang KJ, Hong CH, Lee Y, Lee KS, Roh HW, Back JH, Jung YK, Lim KY, Noh JS, Kim HC, Choi SH, Kim SY, Na DL, Seo SW, Lee S, Son SJ.

Medicine (Baltimore). 2015 Jun;94(23):e919. doi: 10.1097/MD.0000000000000919.

6.

Antipsychotics inhibit glucose transport: Determination of olanzapine binding site in Staphylococcus epidermidis glucose/H(+) symporter.

Babkin P, George Thompson AM, Iancu CV, Walters DE, Choe JY.

FEBS Open Bio. 2015 Apr 15;5:335-40. doi: 10.1016/j.fob.2015.04.006. eCollection 2015.

7.

The effects of atypical antipsychotic usage duration on serum adiponectin levels and other metabolic parameters.

Oral E, Gulec M, Kurt N, Yilmaz S, Aydin N, Kirpinar I.

Eurasian J Med. 2011 Apr;43(1):39-44. doi: 10.5152/eajm.2011.08.

8.

Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment.

Wani RA, Dar MA, Margoob MA, Rather YH, Haq I, Shah MS.

J Neurosci Rural Pract. 2015 Jan;6(1):17-22. doi: 10.4103/0976-3147.143182.

9.

Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.

Chadda RK, Ramshankar P, Deb KS, Sood M.

J Pharmacol Pharmacother. 2013 Jul;4(3):176-86. doi: 10.4103/0976-500X.114596.

10.

Comparative effectiveness of antipsychotic drugs in schizophrenia.

Stroup TS, A Lieberman J, S Swartz M, McEvoy JP.

Dialogues Clin Neurosci. 2000 Dec;2(4):373-9.

11.

Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance.

Panariello F, Perruolo G, Cassese A, Giacco F, Botta G, Barbagallo AP, Muscettola G, Beguinot F, Formisano P, de Bartolomeis A.

J Cell Physiol. 2012 Apr;227(4):1485-92. doi: 10.1002/jcp.22864.

12.

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.

Mundo E, Cattaneo E, Zanoni S, Altamura AC.

Neuropsychiatr Dis Treat. 2006 Jun;2(2):139-48.

13.

Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.

Ablordeppey SY, Altundas R, Bricker B, Zhu XY, Kumar EV, Jackson T, Khan A, Roth BL.

Bioorg Med Chem. 2008 Aug 1;16(15):7291-301. doi: 10.1016/j.bmc.2008.06.030. Epub 2008 Jun 20.

14.

Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the Myths.

Kabinoff GS, Toalson PA, Healey KM, McGuire HC, Hay DP.

Prim Care Companion J Clin Psychiatry. 2003 Feb;5(1):6-14.

15.

Atypical Antipsychotics and Glucose Dysregulation: A Series of 4 Cases.

Gupta S, Lentz B, Lockwood K, Frank B.

Prim Care Companion J Clin Psychiatry. 2001 Apr;3(2):61-65.

16.

Treating Psychotic Symptoms in Elderly Patients.

Targum SD.

Prim Care Companion J Clin Psychiatry. 2001 Aug;3(4):156-163.

17.

A Perspective on the Primary Care of Patients With Behavior, Mood, and Thought Disturbances: Clinical Applications of Olanzapine.

Hay DP, Hurley DJ, McGuire HC, Hay LK.

Prim Care Companion J Clin Psychiatry. 2001 Oct;3(5):195-205.

18.

Diabetes in a high secure hospital.

MacFarlane IA, Gill GV, Finnegan D, Pinkney J.

Postgrad Med J. 2004 Jan;80(939):35-7.

19.

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

Koro CE, Fedder DO, L'Italien GJ, Weiss SS, Magder LS, Kreyenbuhl J, Revicki DA, Buchanan RW.

BMJ. 2002 Aug 3;325(7358):243.

Supplemental Content

Support Center